Open for recruitment
Trial summary
Study to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic ductal adenocardinoma.
Trial details
Short title
RIVER-mPDAC / C3651021
Diagnosis
Pancreatic cancer
Type of treatment
Medical Oncology
Phase
IIb/III
Who can participate
Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.